Irina Nelepcu

Years Active: 2022-2024
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Elena Ethel Vidal-Calvo, Anne Martin-Salazar, Swati Choudhary, Robert Dagil, Sai Sundar Rajan Raghavan, Lara Duvnjak, Mie Anemone Nordmaj, Thomas Mandel Clausen, Ann Skafte, Jan Oberkofler, Kaituo Wang, Mette Ø Agerbæk, Caroline Løppke, Amalie Mundt Jørgensen, Daria Ropac, Joana Mujollari, Shona Willis, Agnès Garcias López, Rebecca Louise Miller, Richard Torbjörn Gustav Karlsson, Felix Goerdeler, Yen-Hsi Chen, Ana R Colaço, Yong Wang, Thomas Lavstsen, Agnieszka Martowicz, Irina Nelepcu, Mona Marzban, Htoo Zarni Oo, Maj Sofie Ørum-Madsen, Yuzhuo Z Wang, Morten Agertoug Nielsen, Henrik Clausen, Michael Wierer, Dominik Wolf, Ismail Gögenur, Thor G Theander, Nader Al-Nakouzi, Tobias Gustavsson, Mads Daugaard, Ali Salanti
Tumor-agnostic cancer therapy using antibodies targeting oncofetal chondroitin sulfate. Nature communications 15 (1) (2024)
Nader Al-Nakouzi, Chris Kedong Wang, Htoo Zarni Oo, Irina Nelepcu, Nada Lallous, Charlotte B Spliid, Nastaran Khazamipour, Joey Lo, Sarah Truong, Colin Collins, Desmond Hui, Shaghayegh Esfandnia, Hans Adomat, Thomas Mandel Clausen, Tobias Gustavsson, Swati Choudhary, Robert Dagil, Eva Corey, Yuzhuo Wang, Anne Chauchereau, Ladan Fazli, Jeffrey D Esko, Ali Salanti, Peter S Nelson, Martin E Gleave, Mads Daugaard
Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer. Nature communications 13 (1) (2022)

Irina Nelepcu.css-eqlu8i{font-size:small;padding-left:4px;}